We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

120 hedge funds and large institutions have $580M invested in Collegium Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more call options, than puts

Call options by funds: $1.2M | Put options by funds: $319K

18% more capital invested

Capital invested by funds: $492M → $580M (+$88.3M)

0.9% more ownership

Funds ownership: 100.74% → 101.64% (+0.9%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 124 → 120 (-4)

16% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 19

17% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 48

Holders
120
Holders Change
-4
Holders Change %
-3.23%
% of All Funds
2.67%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
40
Reduced
48
Closed
19
Calls
$1.2M
Puts
$319K
Net Calls
+$876K
Net Calls Change
-$4.3M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$20M
2
PA
Perceptive Advisors
New York
+$7.61M
3
RHJA
Rice Hall James & Associates
California
+$6.27M
4
UBS AM
UBS AM
Illinois
+$5.01M
5
Macquarie Group
Macquarie Group
Australia
+$3.79M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$14.2M
2
JGC
J. Goldman & Co
New York
-$8.81M
3
Morgan Stanley
Morgan Stanley
New York
-$8.16M
4
MC
Maverick Capital
Texas
-$6.22M
5
Two Sigma Investments
Two Sigma Investments
New York
-$3.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
$3.64M -$2.05M -119,628 -36%
LPL Financial
27
LPL Financial
California
$3.44M -$14K -820 -0.4%
USAA
28
United Services Automobile Association
Texas
$3.23M -$252K -14,754 -7%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$3.22M -$163K -9,521 -5%
GIM
30
Granahan Investment Management
Massachusetts
$3.17M -$212K -12,404 -6%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$2.96M +$2.68M +156,614 +988%
HCMT
32
Highland Capital Management (Texas)
Texas
$2.93M -$2.85M -166,500 -49%
Charles Schwab
33
Charles Schwab
California
$2.84M -$709K -41,455 -20%
Citigroup
34
Citigroup
New York
$2.7M +$1.75M +102,365 +186%
1CM
35
1492 Capital Management
Wisconsin
$2.58M +$2.57M +150,189 New
Invesco
36
Invesco
Georgia
$2.5M +$2.07M +120,780 +482%
SSA
37
Schonfeld Strategic Advisors
New York
$2.25M -$1.28M -75,000 -36%
Citadel Advisors
38
Citadel Advisors
Florida
$1.88M -$1.39M -81,437 -43%
PPA
39
Parametric Portfolio Associates
Washington
$1.75M +$215K +12,558 +14%
AllianceBernstein
40
AllianceBernstein
Tennessee
$1.68M +$1.04M +60,850 +164%
HLA
41
Hamilton Lane Advisors
Pennsylvania
$1.54M -$419K -24,514 -21%
Wells Fargo
42
Wells Fargo
California
$1.38M +$516K +30,135 +60%
OM
43
Opaleye Management
Massachusetts
$1.37M +$1.37M +80,000 New
TCIM
44
TIAA CREF Investment Management
New York
$1.36M +$34.5K +2,014 +3%
TA
45
Teachers Advisors
New York
$1.33M +$7.32K +428 +0.6%
GCP
46
GSA Capital Partners
United Kingdom
$1.14M -$179K -10,463 -14%
MAM
47
Martingale Asset Management
Massachusetts
$994K +$989K +57,833 New
American Century Companies
48
American Century Companies
Missouri
$924K +$921K +53,829 New
TA
49
Teton Advisors
New York
$822K +$457K +26,700 +126%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$799K +$28K +1,638 +4%
1
2
3 4 5

COLL Hedge Fund Activity: Q4 2018 in Review

120 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2018, worth a combined $580M — up 18% from $492M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of COLL and 16 opened new positions — a net loss of 3 holders — while 48 trimmed existing stakes and 40 added.

The largest buyer was Millennium Management, adding an estimated $20M. The largest seller was Sectoral Asset Management, cutting an estimated $14.2M.

  • 120 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2018, down from 124 in Q3 2018.
  • Funds reported $580M of Collegium Pharmaceutical stock for Q4 2018, up 18% quarter-over-quarter.
  • 16 funds opened new Collegium Pharmaceutical positions in Q4 2018 and 19 closed out, a net change of -3 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2018 was Millennium Management, an estimated $20M added.
  • The largest Collegium Pharmaceutical seller in Q4 2018 was Sectoral Asset Management, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2018.